With strong insider buying, these may be two of the hottest stocks to buy now. Here’s why these companies’ directors see huge profits ahead... Read more...
stocks to buy in 2012
- Stocks to Buy Now: Two Companies with Strong Insider Buying
- Why Insiders Love these Stocks to Buy Now
- Stocks to Buy: Why Warren Buffett Is Hunting in Europe
- How to Find Defensive Stocks to Buy for Portfolio Protection
- Stocks to Buy: We Found Two of the Next Big Growth Stories
- Stocks to Buy Now: How to Make Money from Banks
- Stocks to Buy: Huge Growth for a Bargain Price
- 4 Stocks to Buy in the Exploding Cybersecurity Market
- Stocks to Buy: Three Small Cap Stocks for Safety & Dividend Growth
- "Safe" Stocks You Need to Dump Right Now
- The Best Stocks to Buy, According to Top Strategist
- Stocks To Buy Now: Profit from Blockbuster New Drugs in 2013
- Stocks to Buy in 2013: Don't Miss the New Developed Market Leaders
- Stocks to Buy Now: Bet on these Three Casino Stocks for 2013
- How to Choose the Best Global Value Stocks to Buy
- Stocks to Buy Now: Don't Miss This Looming M&A Wave
If you’re looking for stocks to buy now that insiders have faith in, here are three that have seen a surge in buying lately. Read more...
Investment guru Warren Buffett is looking for stocks to buy now in struggling Europe- a region many investors refuse to touch thanks to the destructive Eurozone debt crisis.
"We've bought some European stocks," Buffett said. "And the fact that there are troubles in Europe, and there are plenty of troubles, and they're not going away fast, does not mean you don't buy stocks. We bought stocks when the United States was in trouble, in 2008 and it was in huge trouble, and we spent $15.5 billion in three weeks in between September 15 and October 10."
One reason for Buffett's interest in Europe: plenty of cheap buys.
No one wants to be surprised by a market correction and watch their money disappear. Here’s one way to find defensive stocks to buy now. Read More...
Often investors pile into a growth stock after the huge price increase. Don't make that mistake. Check out these two stocks - a fertilizer firm and a telecom company - with huge potential run ups ahead.
With their high yields - as high as 5.10% right now - this select group of bank stocks is starting to look incredibly appealing to income investors. Here's our breakdown of three juicy bank stocks.
This defense company is way off Wall Street's radar screen. In fact, some investors have been selling, afraid the sequester would hurt the share price. But they're missing something big.
There's a story out of England I heard recently that's one of the most ironic tales of how developments in technology - cybersecurity, in particular - need to be taken more seriously.
The story started in 2009, when 18-year-old Nicholas Webber was arrested for using fraudulent credit card details to pay for a penthouse suite at the Hilton Hotel in Park Lane, Central London.
When police examined Webber's laptop, they found details of 100,000 stolen credit cards linked to losses totaling 16.2 million pounds ($24.6 million)
Turns out Webber ran the Internet crime forum GhostMarket. The site allowed hackers to meet up virtually, create computer viruses and share stolen IDs and private credit card data.
In 2011 Webber was sentenced to five years in prison. Once in prison Webber was allowed to participate in a computer class.
And earlier this year, he hacked the prison computer system.
Here's how to get rich in stocks: Buy elite businesses at a good price and let the dividends compound over the years. That's the safe, steady road to building true wealth.
The key is in selecting the right stocks to buy.
However, most investors starved for solid dividend-payers often overlook one of the safest and most lucrative sectors - small cap dividend stocks.
But therein lies the problem--everybody knows they are great companies. That alone can drive their share prices to dizzying heights.
So investors who limit their choices to the big blue chips can end up paying too much-while missing out on another category of stocks that could make them even more money.
In short, they miss the quality small-cap dividend-payers. Here's why that is a big mistake for most investors.
Small Cap Stocks to Buy
Small-cap stocks can be an individual investor's best friend.
In the period between 1927 and 2009, small-cap value stocks returned 14.9% per year.
Meanwhile, returns on large-cap value stocks averaged roughly 3% less per year.
So why do these small frys outperform their larger cousins?
First of all, their small size makes them fly under the radar of many institutional investors.
What's more, mutual funds and pension funds have billions to invest, making it nearly impossible to buy and sell small stocks without having a huge influence on the price. As a result, a fund manager may find himself chasing a stock higher as he tries to take a meaningful position simply because he's the only big buyer.
Second, because the big fish tend to attract the big bucks, small caps are often ignored by Wall Street analysts. Most analysts simply aren't about to spend precious hours researching a company that no one follows.
So "in-the-know investors" buying small cap dividend payers face a lot less competition and can pick up shares at a good price.
Plus, many of these small cap dividend machines actually have a lot in common with their big brethren.
Like many large-cap, dividend-paying stocks, these companies generate tons of cash flow, have great brand names and wide competitive moats in their respective industries.
The bottom line: Investors who are willing to accept a slightly higher degree of risk should consider investing in small-cap value stocks that pay dividends.
Three Small Cap Dividend Machines
With that in mind, here are three small caps that are members of the Russell Global Small Cap Dividend Achievers Index. To qualify they must have raised their dividends annually for more than 10 years and meet minimum cash volumes.
In short, these are companies that throw off plenty of cash and safe dividends.
Many investors have one or two "safe" stocks they own that, for whatever reason, have become sentimental favorites they never consider selling.
These companies typically are household names, large, and considered by almost everyone - even fund managers - to be safe investments.
That means even if you're not holding such stocks in your personal portfolio, you may own mutual funds that own them, or they could lurk somewhere in your 401(k).
Many "safe" stocks are really hidden time bombs, ready to blow a big hole in your portfolio at any moment.
And as Money Morning Chief Investment Strategist Keith Fitz-Gerald points out, even the most stable, veteran companies can morph into portfolio-destroying dogs.
"Just because you think a stock is safe doesn't mean that the markets will treat it that way," Fitz-Gerald said.
What's more, he said, is that "the very definition of safe has changed," noting how the massive leverage common on Wall Street can unravel a company almost overnight, as happened with Lehman Brothers at the height of the 2008 financial crisis.
It doesn't hurt to have help narrowing down the best stocks to buy - especially when the advice comes from one of the country's best stock analysts.
Tobias Levkovich, Citigroup Inc.'s (NYSE: C) chief equity strategist, has sent a note to clients consisting of 18 recommended stocks and their end-of-year price targets. We've sifted through the list to bring you the 10 stocks that have the highest projected returns based on Citi's targets.
Those returns range from 10.14% to 27.27%.
Here are the companies and their price targets, accompanied by a summary of Citi's analysis for each stock:
One sector offering stocks to buy now is an industry that's been prepping for huge product deliveries in 2013.
I'm talking about Big Pharma.
After being pummeled by generic rivals for the past few years, a few big pharmaceutical companies are fighting back with a new wave of blockbuster drugs that will hit the market in 2013.
More than ever, Big Pharma companies need new revenue streams to battle the "patent cliff - replacing fading profits from drugs that spawned generic competition.
Last year alone, the industry suffered from the expiration of patents for such lucrative name-brand drugs as AstraZeneca PLC's (NYSE ADR: AZN) Seroquel, Pfizer Inc.'s (NYSE: PFE) Lipitor and Wyeth's Protonix, which total accounted for nearly $36 billion in U.S. sales in 2011 and 2012.
But help is on the way.
Pharmaceutical firms logged 39 new drug approvals last year - the most since 1996 - and there are signs the trend could continue through 2013, according to Reuters.
Drugmakers are betting that a new wave of medicines for cancer, diabetes and heart disease will shape up as tomorrow's blockbusters.
European drugmakers, for example, have the potential to deliver new drugs with peak annual sales of $64 billion in 2013-2015 while patent losses will be only $12 billion, according to Deutsche Bank AG (NYSE: DB) estimates.
No doubt about it - Big Pharma is taking aim at generics with both barrels.
That could mean fat profits for savvy investors who focus on high-quality companies with strong late-stage pipelines.
Here are three that are loaded for 2013.
Stocks to Buy: Big Biotech Delivers Big Profits
Innovations in biological science - or biotech - are evolving at the speed of light.In fact, leading edge biotech products and breakthroughs are saving thousands of lives every day.
And business is booming for one biotech bellwether ...
For example, they might like Germany. The MSCI iShares Germany Index Fund (NYSE: EWG) soared more than 32% in 2012.
That's far better than the 15% gain from the S&P 500. It's also much stronger than the 15% gain from the iShares MSCI EAFE Index Fund (NYSE: EFA), which tracks developed-market equities in Europe, Australia, Asia and the Far East.
But amid slowing growth and frothy equity valuations, German stocks appear unlikely to continue such performance in 2013.
That's why investors should check out these other developed market players ready to soar in 2013. They're all expected to deliver gains that could rival Germany's explosive 2012 profits.
That's because casino stocks are promising big returns for shareholders.
Plus, the gaming industry is still in the early stages of what should be a sustained recovery from the financial crisis that had lightened gamblers' wallets.
But identifying the best casino stocks to buy now involves more than a weekend jaunt to Vegas.
Due diligence on gaming stocks now requires a look at gambling's biggest hotspot - Macau, a former Portuguese colony that is now a special administrative region under Chinese rule.
After all, nobody's getting too excited about the recent rally. Europe is about to implode, Japan's in a coma, China's suffering a slowdown and the United States faces the possible fiscal cliff.
That's why I was talking to fund manager George Fraise of SGA Global Growth (MUTF: SGAGX) the other day, to find out where the growth - and potential for profit - is in the global market.
Fraise said he's very bullish on global value stocks, and outlined his strategy for picking the right ones.